Second-Line Treatment Selection in Renal Cell Carcinoma

Navigating Treatment Complexities in First- and Second-Line Therapies for mRCCПодробнее

Panel Discusses Treatment Selection After Progression on EV/PembrolizumabПодробнее

Frontline RCC Treatment Selection: IO/IO Versus IO/TKIПодробнее

UROwebinar: Management of Metastatic kidney cancerПодробнее

Dr Santosh Kumar C | 2nd Line options in Renal Cell CancerПодробнее

Kidney Cancer Conference Highlights from ASCO GU 2023Подробнее

Oncology beyond the Obvious Webinar Series 19Подробнее

Optimising treatment for advanced RCC: Journey through a patient caseПодробнее

Renal Cell Carcinoma | Cases from the Community: Investigators Discuss Available Research Guiding...Подробнее

Drs. McKay, Braun Share Strategies for Patient Selection in First-, Second-Line Advanced RCCПодробнее

Live Webinar on Management of renal cell carcinoma in the new millenniumПодробнее

Selecting and Sequencing Targeted and Immunotherapy Regimens for Patients With RCCПодробнее

How to select 1st line therapy for metastatic renal cell cancer?Подробнее

How and when to use new drugs in metastatic RCCПодробнее

Dr Santosh Kumar | C 2nd Line options in renal Cell cancerПодробнее

Renal Cell Carcinoma: Surgical & Medical Management of High-Risk Renal Cell Carcinoma Webcast (2021)Подробнее

Live Webinar - RCC Webinar - 6 PM - 20 AugПодробнее

How to Choose the Right Combo Therapy - Dr Geynisman - 11/17/22Подробнее

Live Webinar on Management of renal cell carcinoma in the new millenniumПодробнее

Clinical Management of Urothelial Cancer and Renal cell CarcinomaПодробнее